XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1

Note 12 - Segment Information (Tables)

9 Months Ended

Dec. 31, 2021

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Three Months Ended December 31,								Nine Months Ended December 31,
		2021				2020				2021				2020
Revenues:
Sterilization and Disinfection Control		$	13,831			$	13,077			$	43,014			$	37,696
Biopharmaceutical Development			12,756				8,711				32,188				23,791
Calibration Solutions			11,624				12,384				33,769				34,486
Clinical Genomics			16,485				-				16,485				-
Total revenues (a)		$	54,696			$	34,172			$	125,456			$	95,973
Gross profit (loss)
Sterilization and Disinfection Control		$	9,945			$	9,308			$	31,859			$	28,098
Biopharmaceutical Development			8,768				4,616				20,061				15,294
Calibration Solutions			6,090				6,869				18,330				18,962
Clinical Genomics			3,924				-				3,924				-
Reportable segment gross profit			28,727				20,793				74,174				62,354
Corporate and Other (b)			(100	)			(140	)			(196	)			(76	)
Gross profit		$	28,627			$	20,653			$	73,978			$	62,278
Reconciling Items:
Operating expenses			31,139				20,631				69,166				54,216
Operating (loss) income			(2,512	)			22				4,812				8,062
Nonoperating (income) expense, net			(171	)			5,749				1,192				10,651
(Loss) earnings before income taxes		$	(2,341	)		$	(5,727	)		$	3,620			$	(2,589	)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

		December 31,				March 31,
		2021				2021
Sterilization and Disinfection Control		$	2,146			$	2,333
Biopharmaceutical Development			4,482				4,162
Calibration Solutions			5,531				4,683
Clinical Genomics			11,560				-
Total inventories		$	23,719			$	11,178

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration